PABCX
Price
$19.73
Change
+$0.05 (+0.25%)
Updated
Dec 3 closing price
Net Assets
1.06B
RLBBX
Price
$39.47
Change
+$0.11 (+0.28%)
Updated
Dec 3 closing price
Net Assets
269.37B
Interact to see
Advertisement

PABCX vs RLBBX

Header iconPABCX vs RLBBX Comparison
Open Charts PABCX vs RLBBXBanner chart's image
PGIM Balanced C
Price$19.73
Change+$0.05 (+0.25%)
VolumeN/A
Net Assets1.06B
American Funds American Balanced R2
Price$39.47
Change+$0.11 (+0.28%)
VolumeN/A
Net Assets269.37B
PABCX vs RLBBX Comparison Chart in %
View a ticker or compare two or three
VS
PABCX vs. RLBBX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PABCX is a StrongBuy and RLBBX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 269B vs. PABCX (1.06B). PABCX pays higher dividends than RLBBX: PABCX (1.19) vs RLBBX (1.07). PABCX was incepted earlier than RLBBX: PABCX (29 years) vs RLBBX (24 years). PABCX (1.87) is less costly to investors than RLBBX (1.32). PABCX is a more actively managed with annual turnover of: 107.00 vs. RLBBX (44.00). RLBBX has a lower initial minimum investment than PABCX: RLBBX (250) vs PABCX (1000). RLBBX annual gain was more profitable for investors over the last year : 8.46 vs. PABCX (5.05). RLBBX return over 5 years is better than : 34.82 vs. PABCX (20.25).
PABCXRLBBXPABCX / RLBBX
Total Expense Ratio1.811.32137%
Annual Report Gross Expense Ratio1.871.32142%
Fund Existence29 years24 years-
Gain YTD13.41915.79585%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.06B269B0%
Annual Yield % from dividends1.191.07111%
Returns for 1 year5.058.4660%
Returns for 3 years34.1837.3392%
Returns for 5 years20.2534.8258%
Returns for 10 years36.9966.6955%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPOD10.20N/A
N/A
Dune Acquisition Corp II
MET76.31N/A
N/A
MetLife
PRSU33.90-0.14
-0.40%
Pursuit Attractions and Hospitality Inc
CELC97.49-1.00
-1.01%
Celcuity
GDTC1.74-0.07
-3.87%
CytoMed Therapeutics Limited